Modeling healthcare expenditures: Overview of the literature and evidence from a panel time-series model

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 10, Issue 1, 2010, Pages 25-35

  Van Elk, Roel ^a   Mot, Esther ^a   Franses, Philip Hans ^b  

^a CPB NETHERLANDS BUREAU FOR ECONOMIC POLICY ANALYSIS   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Aging; Error correction model; Healthcare expenditures; Time series analysis

Indexed keywords

AGING; ANALYTICAL ERROR; BUDGET; CORRELATION COEFFICIENT; COST CONTROL; COST UTILITY ANALYSIS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE FINANCING; HEALTH CARE NEED; HEALTH CARE SYSTEM; INCOME; LIFESTYLE; MEDICAL TECHNOLOGY; REVIEW; STATISTICAL PARAMETERS; TIME SERIES ANALYSIS; HUMAN; LIFE EXPECTANCY; QUALITY OF LIFE; STATISTICAL MODEL; TIME;

AGING; BUDGETS; HEALTH CARE COSTS; HEALTH EXPENDITURES; HUMANS; INCOME; LIFE EXPECTANCY; MODELS, ECONOMIC; QUALITY OF LIFE; TIME FACTORS;

EID: 77950894641     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/erp.09.72     Document Type: Review

References (37)

1. Tomono N, Shiro H. The smaller number of infuenza patients with neuropsychiatric events had taken oseltamivir beforehand. Kansenshogaku Zasshi 82(6), 613-618 (2008).
2. Okamoto E. Incidence of injuries after infuenza using health insurance claims. Jpn. J. Pharmacoepidemiol. 21(Suppl.), 50-51 (2009).
3. Jhee SS, Yen M, Ereshefsky L et al. Low penetration of oseltamivir and its carboxylate into cerebrospinal fuid in healthy Japanese and Caucasian volunteers. Antimicrob. Agents Chemother. 52(10), 3687-3693 (2008).
4. Shun-Shin M, Thompson M, Heneghan C, Perera R, Harnden A, Mant D. Neuraminidase inhibitors for treatment and prophylaxis of infuenza in children: systematic review and meta-analysis of randomized controlled trials. BMJ 339, b3172 (2009).
5. Cutler DM. Your Money or Your Life: Strong Medicine for America s Health Care System. Oxford University Press NY USA 2004).
6. Gerdtham UG, Jönsson B. International comparisons of health expenditure: theory, data and econometric analysis. In: Handbook of Health Economics (Volume 1). Culyer AJ, Newhouse JP (Eds). Elsevier, Amsterdam, The Netherlands (2000).
7. Baumol W. Macroeconomics of unbalanced growth; the anatomy of urban crisis. Am. Econ. Rev. 57, 415-426 (1967).
8. Newhouse JP. Medical care expenditure:a cross-national survey. J. Hum. Resour. 12, 115-125 (1977).
9. Roberts J. Sensitivity of elasticity estimates for OECD health care spending: analysis of a dynamic heterogeneous data feld. Health Econ. 8, 459-472 (1999).
10. Ariste R, Carr J. New considerations on the empirical analysis of health expenditures in Canada: 1966-1998. In: Health Policy Research Working Paper Series 02-06. Health Canada, Canada (2003).
11. Murillo C, Piatecki C, Saez M. Health care expenditure and income in Europe. Health Econ. 2, 127-138 (1993).
12. O'Connell JM. The relationship between health expenditures and the age structure of the population in OECD countries. Health Econ. 5, 573-578 (1996).
13. Clemente J, Marcuello C, Montanes A, Pueyo F. On the international stability of health care expenditure functions: are government and private functions similar? J. Health Econ. 23, 589-613 (2004).
14. Okunade AA, Suraratdecha C. Health care expenditure inertia in the OECD countries: a heterogeneous analysis. Health Care Manag. Sci. 3, 31-42 (2000).
15. Baltagi BH, Griffn JM. Pooled estimators vs. their heterogenous counterparts in the context of dynamic demand for gasoline. J. Econom. 77, 303-327 (1997).
16. Roberts J. Spurious regression problems in the determinants of health care expenditure: a comment on Hitiry (1997). Appl. Econ. Letter 7, 279-283 (2000).
17. Dreger C, Reimers HE. Health Care Expenditures in OECD-Countries: a Panel Unit Root and Cointegration Analysis. IZA DP no. 1469. Institute for the Study of Labor, Germany (2005).
18. Okunade AA, Murthy VNR. Technology as a 'major driver' of health care costs: a cointegration analysis of the Newhouse conjecture. J. Health Econ. 21, 147-159 (2002).
19. Gerdtham UG, Löthgren M. New panel results on cointegration of international health expenditure and GDP. Appl. Econ. 34, 1679-1686 (2002).
20. Jewell T, Lee J, Tieslau M, Strazicich MC. Stationarity of health expenditures and GDP: evidence from panel unit root tests with heterogeneous structural breaks. J. Health Econ. 22, 313-323 (2003).
21. Okunade AA, Karakus MC, Okeke CV. Determinants of health expenditure growth of the OECD countries: jackknife resampling plan estimates. Health Care Manag. Sci. 7, 173-183 (2004).
22. Murthy NRV, Okunade AA. Managed care, defcit fnancing, and aggregate health care expenditure in the United States: a cointegration analysis. Health Care Manag. Sci. 3, 279-285 (2000).
23. Murthy NRV, Ukpolo V. Aggregate health care expenditure in the United States: evidence from cointegration tests. Appl. Econ. 26, 797-802 (1994).
24. Gerdtham UG, Jönsson B. Price and quantity in international comparisons of health care expenditure. Appl. Econ. 23, 1519-1528 (1991).
25. Hall RE, Jones CI. The Value of Life and the Rise in Health Spending. National Bureau of Economic Research Working Paper 10737 (2004)
26. OECD. Projecting OECD health and long-term care expenditures: what are the main drivers? In: Economics Department Working Papers. OECD, Paris, France, 477 (2006).
27. Ligthart M. Determinanten van de gezondheidszorguitgaven, Een analyse op basis van paneldata. CPB Memorandum 186 (2006).
28. Zweifel P, Felder S, Meiers M. Aging of population and health care expenditure: a red herring? Health Econ. 8, 485-496 (1999).
29. Raitano M. The impact of death-related costs on health care expenditure: a survey. In: ENEPRI Research Report. Centre for European Policy Studies, Brussels, Belgium, 17 (2006).
30. Christiansen T, Bech M, Lauridsen J, Nielsen P. Demographic changes and aggregate health-care expenditure in Europe. ENEPRI Research Report 32, AHEAD WP6B (2006).
31. Gerdtham UG, Sögaard J, MacFarlan M, Oxley H. The determinants of health expenditure in the OECD countries. In: Health, the Medical Profession, and Regulation. Zweifel P (Ed.). Kluwer Academic Publishers, MA, USA, 113-134 (1998).
32. Freeman DG. Is health care a necessity or a luxury? Pooled estimates of income elasticity from US state-level data. Appl. Econ. 35, 495-502 (2003).
33. Weisbrod B. The health care quadrilemma: an essay on technological change, insurance, quality of care and cost containment. J. Econ. Lit. 29, 523-552 (1991).
34. Barros PP. The black box of health care expenditure growth determinants. Health Econ. 7, 533-544 (1998).
35. Leu R. The public-private mix and international health care costs, In: Public and Private Health Services. Culyer A, Jönsson B (Eds). Basil Blackwell, Boston, USA, 41-63 (1986).
36. Boswijk HP. Testing for an unstable root in conditional and structural error correction models. J. Econom. 63, 37-60 (1994).
37. Okunade AA, Karakus MC. Unit root and cointegration tests: time-series versus panel estimates for international health expenditure models. Appl. Econ. 33, 1131-1137 (2001).